Fetal and maternal safety considerations for in utero therapy clinical trials: iFeTiS consensus statement. Mol Ther. 2020.
The hollow fiber bioreactor as a stroma-supported, serum-free ex vivo expansion platform for human umbilical cord blood cells. Biotechnol J. 2014..
Stem cell tracking with optically active nanoparticles. Am J Nucl Med Mol Imaging. 2013;3(3):232-46..